Eric Lefkofsky Tempus Unicorn Funding

Tempus Unicorn is a Chicago based healthcare organization led by the Groupon co-founder and the CEO Eric Lefkofsky. The company has partnered with several Clinics with the aim of enhancing doctors with skills of using data in treating cancer patients. Mayo clinic center is the latest company with high profile health care in a series of partnerships with Tempus around the state.

Tempus Company was founded in the year 2015 and has then drawn considerable attention to other organizations. It has a partnership with other cancer research hospitals including the Cleveland Clinic, University of Michigan, the University of Chicago, Northwestern University, Duke University School of Medicine, Mayo Clinic, and knight Institute of cancer in OHSU. Tempus has therefore worked with more than half of Medical Research Centers in the United States.

The start-up of the company has continuously increased on a monthly basis at high rates. On Chicago News magazine, Eric Lefkofksy stated that the company is employing additional of thirty workers to support the first growing organization having about 400 workers. The demanding factor has then raised a need to fund Tempus to stabilize the financial state of development. Unicorn has therefore raised $70 million round and consequently, on 20th March 2018, new investors including T. Rowe and Kinship Trust companies and the existing investors funded Tempus $80 million that brought a total of $210 million.

Lefkofsky announced a partnership with Mayo Clinic Center that Individualized Medicine in treating cancer patients. Therefore, Tempus operates molecular sequencing and analysis of 1000 patients diagnosed at Mayo Clinic and participates in studies related to immunotherapy for breast cancer, lymphoma, lung cancer, bladder cancer, melanoma, and endocrine therapy used for advanced breast cancer.

Tempus has initiated a development plan of building a database library that accommodates all the resources enough for the researchers. Unicorn is itself an operational system for oncologists that let professional workers use data to figure treatment progress and how patients response to a particular medicine. Tempus employs about 100 expertise medical practitioners at its River North headquarters and likely to increase the number by hiring more software engineers and computational biologists. Tempus’ office includes a genomic sequencing technology lab that can process over 50,000 patients yearly.

To Learn More Click Here

Comments are closed, but trackbacks and pingbacks are open.